SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brera Holdings Plc engages in the business of football division progression, global football player transfer service, sponsorship services, football school services, and consulting services on football projects. The company was founded on June 30, 2022 and is headquartered in Dublin, Ireland.

Brera Holdings PLC - Ordinary Shares - Class B

Brera Holdings PLC

BREA is trending due to its planned rebranding as Solmate, a Solana-backed digital asset treasury, fueled by a substantial private investment, with the community actively debating its potential for further gains or a significant pullback. Discussions include comparisons to similar stocks and speculation about short squeezes, float size, and potential after-hours movement. Some traders express concerns about dilution and caution against bag holding.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

FedEx ($FDX) is trending after reporting earnings that beat expectations, but the stock is down due to a weaker-than-expected outlook and concerns about the impact of tariffs; the community is debating whether this presents a buying opportunity or signals further downside, with some analysts remaining bullish due to cost-cutting measures and potential for a future freight spin-off.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending as the stock rebounds from a recent dip, fueled by renewed optimism in the obesity and MASH treatment space following acquisition news in the sector. The community is actively discussing potential buyout scenarios and the value of Viking's pipeline, particularly its VK2735 and VK2809 assets, with some speculating about upcoming news or data releases. Sentiment suggests that the stock may be oversold, with many expressing confidence in its long-term potential despite recent volatility.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co.

Disney is trending amid discussions around free speech and potential boycotts related to the removal of Jimmy Kimmel's show, sparking debates over political polarization and censorship. The community is divided, with some supporting Disney's decision and others criticizing it as an attack on free speech. Broader conversations include the company's financial performance, streaming strategy, and the impact of political stances on its brand.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is trending as investors discuss its potential pivot towards AI and high-performance computing, spurred by recent CEO commentary. Community members are weighing the company's valuation against its peers, anticipating a possible revaluation, and are closely watching for news of potential hyperscaler partnerships. The stock's high short interest is also fueling speculation of a potential short squeeze.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending due to a surprise $5 billion investment and partnership with Nvidia, sending the stock soaring as the community discusses the implications for AI and chip manufacturing. Many see this as a major win for Intel, while some analysts express skepticism, and the partnership's impact on competitors like AMD is also a hot topic. Discussions range from the potential for Intel's comeback to speculation about future partnerships and government influence.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is trending amid discussions of a potential short squeeze due to high short interest, although some community members cite insider selling as a concern. The stock's valuation, potential ventures into AI, and comparisons to other mining stocks are also being actively debated. Additionally, some are referencing a Compass Point rating of "neutral" with a price target of $18.00.

MicroAlgo, Inc. operates as a holding company, which engages in the development and application of bespoke central processing algorithms. Its services include algorithm optimization, accelerating computing power without the need for hardware upgrades, lightweight data processing, and data intelligence. The company was founded May 14, 2018 and is headquartered in New York, NY.

MicroAlgo Inc

MicroAlgo ($MLGO) is gaining traction as traders discuss its potential for a short squeeze, driven by its low float and high short interest. Community members are drawing comparisons to previous high-flying stocks and anticipating significant price movement. However, some caution about the company's Chinese connections and history of reverse splits.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending as investors assess the potential impact of FedEx's earnings and the ending of tariff exemptions. The community is actively discussing the stock's attractive dividend yield and speculating on a potential bottom, while also weighing concerns about declining volumes and the risk of a dividend cut. Some traders are noting the stock's oversold condition and multi-year lows, sparking debates about whether it represents a value opportunity or a value trap.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending due to strong revenue growth, particularly with Recorlev, leading to raised full-year revenue guidance, prompting community discussion around profitability and potential buyouts. Investors are impressed by the company's trajectory, with some anticipating further gains and analysts possibly adjusting price targets. Community members are highlighting the increased value of Recorlev and the potential for the company's technology.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CG Oncology, Inc. (CGON) Moves 5.5% Higher: Will This Strength Last?

CG Oncology, Inc. (CGON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates

Arbutus (ABUS) delivered earnings and revenue surprises of +150.00% and +496.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success

Company News for May 14, 2025

CG Oncology, Inc. (CGON) Reports Q1 Loss, Lags Revenue Estimates

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Tops Revenue Estimates

Malin Announces Profitable CG Oncology Exit

Malin (MLLNF) has released an update. Malin Corporation PLC has successfully sold its entire stake in CG Oncology for approximately 28.5 million...

A Closer Look at 9 Analyst Recommendations For CG Oncology

Decoding 10 Analyst Evaluations For CG Oncology

CG Oncology (NASDAQ:CGON) Receives Buy Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of CG Oncology (NASDAQ:CGON - Free Report) in a report issued on Thursday, Benzinga reports. HC Wainwright currently has a $75.00 target price on...

CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Irvine, CA.

Cg Oncology Inc.

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

Current Price	$38.82
Prev Close	$37.72
Open	$38.14
Dividend Yield	0.00%
50-Day Moving Average	$27.78
Beta	1.62
Avg. Volume	582,736.95
PE Ratio	-22.44

52-Week High	$40.47
52-Week Low	$14.80
Market Capitalization	$2.88B
EPS (Annual)	-$1.16
Price to Book	4.29
Revenue Per Employee	$10,079.65
Enterprise Value/EBITDA	N/A

CGON
Cg Oncology Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CGON News

CGON Cg Oncology Inc.